Here, we report on a case of a woman diagnosed with advanced non-small cell lung cancer (NSCLC) and started on anti-PD-L1 durvalumab who developed an isolated pendular torsional nystagmus and tested positive for anti-Ma2 antibodies. This evidence concerns the gene PNMA2 and non-small cell lung carcinoma.